Advanced Glycation End-Products (AGEs), play a crucial part in advancing the process of cellular skin aging and its link to chronological age was re-assessed. AGEs accumulation alters cell structure and function of most types of skin cells, affecting skin’s mechanical and physiological properties, following the molecular transformations. Slowdown AGEs accumulation rate in skin, although a potent anti-aging strategy, is difficult and tricky. The lack of working methods for In-Vitro and In-Vitro measuring AGEs level complicates the evaluation and prediction of active ingredients’ ability to affect cellular AGEs accumulation. A two-step In-Vitro systematic screening method is proposed and three different cosmetic active ingredients were selected for its demonstration, using BSA-Glucose and Collagen-Glucose predicting models. Candidates’ effects on AGEs accumulation were evaluated as standalone, and when formulated in a blend. Additionally, the potency of non-invasive auto-fluorescence in-vivo measurement to detect AGEs levels among subjects of different ages was demonstrated. The results are presented in this work and the potential contribution of the proposed system to assist the desired inhibition of AGEs accumulation in skin is discussed.
References
[1]
Baynes, J.W. (2001) The Role of AGEs in Aging: Causation or Correlation. Experimental Gerontology, 36, 1527-1537. https://doi.org/10.1016/S0531-5565(01)00138-3
[2]
Goldin, A., Beckman, J.A., Schmidt, A.M. and Creager, M.A. (2006) Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury. Circulation, 114, 597-605. https://doi.org/10.1161/CIRCULATIONAHA.106.621854
[3]
Ott, C., Jacobs, K., Haucke, E., Santos, A.N., Grune, T. and Simm, A. (2014) Role of Advanced Glycation End Products in Cellular Signaling. Redox Biology, 2, 411-429. https://doi.org/10.1016/j.redox.2013.12.016
[4]
Aldini, G., Vistoli, G., Stefek, M., Chondrogianni, N., Grune, T., Sereikaite, J., et al. (2013) Molecular Strategies to Prevent, Inhibit, and Degrade Advanced Glycoxidation and Advanced Lipoxidation End Products. Free Radical Research, 47, 93-137. https://doi.org/10.3109/10715762.2013.792926
[5]
Perrone, A., Giovino, A., Benny, J. and Martinelli, F. (2020) Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 3818196. https://doi.org/10.1155/2020/3818196
[6]
Jeanmaire, C., Danoux, L. and Pauly, G. (2001) Glycation during Human Dermal Intrinsic and Actinic Ageing: An in Vivo and in Vitro Model Study. British Journal of Dermatology, 145, 10-18. https://doi.org/10.1046/j.1365-2133.2001.04275.x
[7]
Van Putte, L., De Schrijver, S. and Moortgat, P. (2016) The Effects of Advanced Glycation End Products (AGEs) on Dermal Wound Healing and Scar Formation: A Systematic Review. Scars, Burns & Healing, 2, 1-14. https://doi.org/10.1177/2059513116676828
[8]
Thomas, M.C. (2011) Advanced Glycation End Products. Diabetes and the Kidney, 170, 66-74. https://doi.org/10.1159/000324945
[9]
de la Maza, M.P., Garrido, F., Escalante, N., Leiva, L., Barrera, G., Schnitzler, S., et al. (2012) Fluorescent Advanced Glycation End-Products (Ages) Detected by Spectro-Photofluorimetry, as a Screening Tool to Detect Diabetic Microvascular Complications.
[10]
Valencia, J.V., Weldon, S.C., Quinn, D., Kiers, G.H., DeGroot, J., TeKoppele, J.M., et al. (2004) Advanced Glycation End Product Ligands for the Receptor for Advanced Glycation End Products: Biochemical Characterization and Formation Kinetics. Analytical Biochemistry, 324, 68-78. https://doi.org/10.1016/j.ab.2003.09.013
[11]
Sajithlal, G., Chithra, P. and Chandrakasan, G. (1998) Advanced Glycation End Products Induce Crosslinking of Collagen in Vitro. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1407, 215-224. https://doi.org/10.1016/S0925-4439(98)00043-X
[12]
Portugal-Cohen, M., Horev, L., Ruffer, C., Schlippe, G., Voss, W., Oron, M., et al. (2012) Non-Invasive Skin Biomarkers Quantification of Psoriasis and Atopic Dermatitis: Cytokines, Antioxidants and Psoriatic Skin Auto-Fluorescence. Biomedicine & Pharmacotherapy, 66, 293-299. https://doi.org/10.1016/j.biopha.2011.12.009
[13]
Shin, S., Lee, J.-A., Kim, M., Kum, H., Jung, E. and Park, D. (2015) Anti-Glycation Activities of Phenolic Constituents from Silybum marianum (Milk Thistle) Flower in Vitro and on Human Explants. Molecules, 20, 3549-3564. https://doi.org/10.3390/molecules20033549
[14]
Wu, C.-H., Huang, S.-M. and Yen, G.-C. (2011) Silymarin: A Novel Antioxidant with Antiglycation and Antiinflammatory Properties in Vitro and in Vivo. Antioxidants & Redox Signaling, 14, 353-366. https://doi.org/10.1089/ars.2010.3134
[15]
Huseini, H.F., Larijani, B., Heshmat, R., Fakhrzadeh, H., Radjabipour, B., Toliat, T., et al. (2006) The Efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 20, 1036-1039. https://doi.org/10.1002/ptr.1988
[16]
Sotoudeh, R., Mousa-Al-Reza Hadjzadeh, Z.G. and Aghaei, A. (2019) The Anti-Diabetic and Antioxidant Effects of a Combination of Commiphora mukul, Commiphora myrrha and Terminalia chebula in Diabetic Rats. Avicenna Journal of Phytomedicine, 9, 454.
[17]
Portugal-Cohen, M., Oron, M., Merrik, E., Ben-Amitai, D., Yogev, H. and Zvulunov, A. (2011) A Dead Sea Water-Enriched Body Cream Improves Skin Severity Scores in Children with Atopic Dermatitis. Journal of Cosmetics, Dermatological Sciences and Applications, 1, 71-78. https://doi.org/10.4236/jcdsa.2011.13012
[18]
Katz, U., Shoenfeld, Y., Zakin, V., Sherer, Y. and Sukenik, S. (2012) Scientific Evidence of the Therapeutic Effects of Dead Sea Treatments: A Systematic Review. Seminars in Arthritis and Rheumatism, 42, 186-200. https://doi.org/10.1016/j.semarthrit.2012.02.006
[19]
Cohen, D., Portugal-Cohen, M., Blinderman, A., Barak, D. and Ma’or, Z. (2021) Inventor Anti-Glycation Composition. Israeli Patent Application No. 283583. ISRAEL.
